In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.
Authors: Feng X; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.; Pancreas Institute, Nanjing Medical University, Nanjing 210000, China.; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Yang C; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.; Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin 150086, China., Huang Y; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Su D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Wang C; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Wilson LL; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Yin L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Tang M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Li S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Chen Z; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Zhu D; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Wang S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Zhang S; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Zhang J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Zhang H; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Nie L; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Huang M; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Park JI; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Hart T; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Jiang D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030., Jiang K; Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.; Pancreas Institute, Nanjing Medical University, Nanjing 210000, China.; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China., Chen J; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Sep 24; Vol. 121 (39), pp. e2406325121. Date of Electronic Publication: 2024 Sep 19.
Publication Type: Journal Article
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2406325121